Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - Sequent Scientific

Sequent Scientific

BSE: 512529|NSE: SEQUENT|ISIN: INE807F01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 19, 15:53
65.30
-2.2 (-3.26%)
VOLUME 31,048
LIVE
NSE
Nov 19, 15:57
65.30
-2.35 (-3.47%)
VOLUME 402,140
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Profit & Loss account of Sequent Scientific

------------------- in Rs. Cr. -------------------
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
INCOME
Revenue From Operations [Gross] 161.37 102.24 91.82 396.32 346.28
Less: Excise/Sevice Tax/Other Levies 0.00 1.23 3.82 14.08 18.50
Revenue From Operations [Net] 161.37 101.01 88.00 382.24 327.78
Other Operating Revenues 6.31 4.99 2.71 14.53 56.46
Total Operating Revenues 167.68 106.01 90.72 396.77 384.24
Other Income 13.53 24.27 19.07 11.58 3.56
Total Revenue 181.20 130.28 109.78 408.35 387.79
EXPENSES
Cost Of Materials Consumed 77.34 30.66 44.85 155.12 170.47
Purchase Of Stock-In Trade 20.23 49.14 28.12 54.15 13.69
Changes In Inventories Of FG,WIP And Stock-In Trade -2.95 -0.42 -0.44 11.72 9.03
Employee Benefit Expenses 10.97 11.85 17.90 38.20 39.85
Finance Costs 3.22 0.39 0.42 16.44 43.37
Depreciation And Amortisation Expenses 7.26 3.67 3.25 24.29 24.94
Other Expenses 58.92 33.17 30.85 100.75 97.18
Total Expenses 175.00 128.45 124.95 400.66 398.53
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 6.20 1.82 -15.17 7.69 -10.74
Exceptional Items 0.00 -1.16 0.00 -0.54 -23.89
Profit/Loss Before Tax 6.20 0.66 -15.17 7.15 -34.63
Tax Expenses-Continued Operations
Current Tax 1.33 0.04 0.00 0.00 1.70
Less: MAT Credit Entitlement 1.33 -2.83 0.00 0.00 0.00
Deferred Tax -1.38 0.00 0.00 0.07 0.00
Total Tax Expenses -1.38 2.87 0.00 0.07 1.70
Profit/Loss After Tax And Before ExtraOrdinary Items 7.59 -2.20 -15.17 7.08 -36.33
Profit/Loss From Continuing Operations 7.59 -2.20 -15.17 7.08 -36.33
Profit Loss From Discontinuing Operations 0.00 408.61 15.15 0.00 77.63
Net Profit Loss From Discontinuing Operations 0.00 408.61 15.15 0.00 77.63
Profit/Loss For The Period 7.59 406.41 -0.01 7.08 41.31
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) 0.31 16.77 0.00 0.34 14.44
Diluted EPS (Rs.) 0.31 16.66 0.00 0.34 12.22
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS
Imported Raw Materials 0.00 0.00 0.00 72.00 92.14
Indigenous Raw Materials 0.00 0.00 0.00 83.12 93.69
STORES, SPARES AND LOOSE TOOLS
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 0.00 4.85 0.00 0.00 0.00
Tax On Dividend 0.00 0.99 0.00 0.00 0.00
Equity Dividend Rate (%) 10.00 10.00 0.00 0.00 0.00
Source : Dion Global Solutions Limited

Results of Sequent Scienti

  • News
  • Results
  • Estimates
  • Analysis

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for sequentscientific
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.